We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+14.47%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$2.43B
Cap. Flow
+$474M
Cap. Flow %
2.84%
Top 10 Hldgs %
21.56%
Holding
1,687
New
116
Increased
1,133
Reduced
405
Closed
29

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$74.8M
2
PBCT
People's United Financial Inc
PBCT
+$73.6M
3
CB icon
Chubb
CB
+$72.7M
4
CAT icon
Caterpillar
CAT
+$71.4M
5
TGT icon
Target
TGT
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 19.51%
2 Financials 12.5%
3 Healthcare 12.23%
4 Industrials 11.06%
5 Consumer Discretionary 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRA
1026
DELISTED
ProAssurance
PRA
$491K ﹤0.01%
14,190
+389
+3% +$15.8K
WKC icon
1027
World Kinect Corp
WKC
$1.96B
$490K ﹤0.01%
16,970
+1,151
+7% +$30.2K
DK icon
1028
Delek US
DK
$3.87B
$489K ﹤0.01%
13,433
+106
+0.8% +$3.61K
X
1029
DELISTED
US Steel
X
$488K ﹤0.01%
25,044
+2,495
+11% +$53.1K
NTCT icon
1030
NETSCOUT
NTCT
$2.86B
$486K ﹤0.01%
17,297
+1,489
+9% +$39.6K
IART icon
1031
Integra LifeSciences
IART
$1.54B
$484K ﹤0.01%
8,690
+1,922
+28% +$97.9K
VSH icon
1032
Vishay Intertechnology
VSH
$5.86B
$480K ﹤0.01%
26,015
+2,638
+11% +$52.7K
LMNX
1033
DELISTED
Luminex Corp
LMNX
$480K ﹤0.01%
20,881
+239
+1% +$6K
PACB icon
1034
Pacific Biosciences
PACB
$422M
$479K ﹤0.01%
66,310
+1,420
+2% +$10.3K
SAM icon
1035
Boston Beer
SAM
$1.88B
$477K ﹤0.01%
1,618
+177
+12% +$48.4K
ELAN icon
1036
Elanco Animal Health
ELAN
$12.4B
$472K ﹤0.01%
+14,715
New +$453K
TTEK icon
1037
Tetra Tech
TTEK
$8.23B
$469K ﹤0.01%
39,365
+1,190
+3% +$13.3K
AVNS icon
1038
Avanos Medical
AVNS
$1.17B
$466K ﹤0.01%
10,929
+1,450
+15% +$64.9K
ESPR
1039
DELISTED
Esperion Therapeutics
ESPR
$466K ﹤0.01%
11,600
+102
+0.9% +$4.58K
CHK
1040
DELISTED
Chesapeake Energy Corporation
CHK
$465K ﹤0.01%
750
+156
+26% +$87.3K
OSK icon
1041
Oshkosh
OSK
$9.67B
$462K ﹤0.01%
6,152
+1,033
+20% +$76.3K
EPC icon
1042
Edgewell Personal Care
EPC
$1.27B
$461K ﹤0.01%
10,504
+1,069
+11% +$44.5K
WWW icon
1043
Wolverine World Wide
WWW
$1.54B
$461K ﹤0.01%
12,895
+275
+2% +$9.61K
RINF icon
1044
ProShares Inflation Expectations ETF
RINF
$18.5M
$460K ﹤0.01%
16,782
-20,136
-55% -$554K
VNDA icon
1045
Vanda Pharmaceuticals
VNDA
$312M
$460K ﹤0.01%
24,981
+321
+1% +$7.31K
MANH icon
1046
Manhattan Associates
MANH
$8.97B
$459K ﹤0.01%
8,331
+1,244
+18% +$63.6K
GNTX icon
1047
Gentex
GNTX
$4.88B
$458K ﹤0.01%
22,147
+4,054
+22% +$84.7K
ALDR
1048
DELISTED
Alder Biopharmaceuticals
ALDR
$457K ﹤0.01%
33,445
+4,143
+14% +$53.7K
MMSI icon
1049
Merit Medical Systems
MMSI
$4.43B
$456K ﹤0.01%
7,377
+226
+3% +$12.8K
CHX
1050
DELISTED
ChampionX
CHX
$453K ﹤0.01%
11,023
+1,047
+10% +$38.7K

Similar funds

ProShare Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, ProShare Advisors held 1,687 positions worth $16.7B, up 17% from $14.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ProShare Advisors's Q1 2019 filing shows 116 new, 1,133 increased, 405 reduced and 29 closed positions. Its largest new stake was Fox Class A: 268,496 shares worth $9.86M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $39M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • ProShare Advisors's largest Q1 2019 buy was Fox Class A: 268,496 shares worth $9.86M.
  • ProShare Advisors added most to RTX Corp in Q1 2019, an estimated $74.8M increase.
  • ProShare Advisors's biggest Q1 2019 reduction was Apple, cutting an estimated $9.37M.
  • ProShare Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $39M.
  • ProShare Advisors's ten largest holdings make up 22% of its $16.7B portfolio in Q1 2019.
  • ProShare Advisors opened 116 new positions and closed 29 in Q1 2019.
  • ProShare Advisors's portfolio value rose 17% quarter-over-quarter to $16.7B.

Based on ProShare Advisors's 13F filing for Q1 2019, filed 15 May 2019.